Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
Saved in:
Main Authors: | Guangting Zeng (Author), Yuchi Zhou (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United StatesResearch in context
by: Ayodeji Adegunsoye, et al.
Published: (2023) -
Hair loss after SARS-CoV2 Infection
by: Beata Kuczyńska, et al.
Published: (2022) -
Ulcerative colitis after SARS-CoV-2 infection
by: Sofia Kartsoli, et al.
Published: (2022) -
Extra-pulmonary manifestations of the novel coronavirus infection SARS-CoV-2
by: Onelis Góngora Gómez, et al.
Published: (2020) -
Competitive sport after SARS-CoV-2 infection in children
by: Giulia Cafiero, et al.
Published: (2021)